Reito WATANABE
Partner @ DOGAN beta
Fukuoka, Japan
Reito WATANABE is a seed investor at DOGAN beta in Fukuoka focused on Software and Health Care. He joined the Corporation Dogan in 2012. Consistently responsible for the investment of venture companies with Yukari in Kyushu. Co., Ltd. was established Dogan beta specializing in venture support in 2017. Under the hypothesis that by the diversity of employment that new industries produce a healthy metabolism of the local economy are prompted,provide the beginning and service the financial technique of VC investment. Also involved in, such as the establishment of and the launch of the co-working space "OnRAMP", "Fukuoka Startup Cafe".
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Reito WATANABE invests in
Stages Reito WATANABE invests in
Countries Reito WATANABE invests in
Investment Focus
Industry
- Software 2 (33%)
- Health Care 2 (33%)
- Information Technology 2 (33%)
- Medical 1 (17%)
- Rehabilitation 1 (17%)
Stage
- Seed 3 (50%)
- Pre-Seed 1 (17%)
- Series A 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Foodcam
|
Foodcam aims to build a comprehensive overseas distribution infrastructure for Japanese food products, enabling manufacturers and suppliers to efficiently expand into international markets through streamlined logistics, supply chain management, and global distribution solutions. | Seed / Jun 25, 2026 | |
Digireha
|
Digireha is an IT company that provides a tool for rehabilitation by combining digital art and sensors. | Seed / Feb 26, 2026 | |
|
Digireha
|
Digireha is an IT company that provides a tool for rehabilitation by combining digital art and sensors. | Seed / Oct 25, 2024 | |
GEOFLA
|
Geofra develops Planning and creation of items that rejuvenate the movement of people in physical areas, regional revitalization initiatives | Pre-Seed / Dec 07, 2023 | |
Medmain
|
Medmain's mission is to create a world where medical services can be accessed with technology anywhere, anytime. We are tackling these challenges with our product, PidPort's, deep learning-powered pathology analysis and digital telepathology consultation platform. | $152.1M / Series A / Aug 24, 2020 | |
|
Medmain
|
Medmain's mission is to create a world where medical services can be accessed with technology anywhere, anytime. We are tackling these challenges with our product, PidPort's, deep learning-powered pathology analysis and digital telepathology consultation platform. | $14.2M / Seed / Aug 17, 2018 |
Co-Investors
Deepcore
2 deals together
One Capital
2 deals together
Denkyo Group Holdings Co.
1 deal together
Fukuoka Wajiro Hospital
1 deal together
Harumi Maru
1 deal together
Hibishin Capital
1 deal together
About DOGAN beta
They believe that the fundamental challenge facing the local economy is the lack of employment diversity. Although it is a simple example, it is easier to understand if you compare the Tokyo metropolitan area with Kyushu and list the companies that can achieve annual income of 10 million yen at the age of 30 (probably with a head office in KyushuMost companies with the highest annual income will be infrastructure company
DOGAN beta Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Reito WATANABE
Partner
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Reito WATANABE invest in?
Reito WATANABE invests primarily in Software, Health Care and Information Technology startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Reito WATANABE last invest?
The most recent investment recorded for Reito WATANABE closed in Jun 2026. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
